All bills
H.R. 10037·119th Congress·House Bill

Virtual-Based Opioid Treatment for Veterans Act

Stage not supplied

The source supplies the latest action, but no lifecycle stage.

Latest action (10 Aug 2026): Referred to the Subcommittee on Health.

What this bill does

H.R. 10037, the Virtual-Based Opioid Treatment for Veterans Act, proposes a pilot program to expand access to virtual opioid treatment for veterans. The Secretary of Veterans Affairs would be directed to establish this program within 180 days of enactment. The program would involve outreach to veterans and their families about virtual treatment options, developing referral networks designed to overcome treatment barriers, and creating a referral pipeline to these programs. It would also ensure healthcare providers and peer support specialists are informed about these virtual options.

This bill primarily affects veterans enrolled in the Department of Veterans Affairs' patient enrollment system. It aims to provide them with alternative treatment methods for opioid use disorder, particularly those facing difficulties accessing traditional in-person care. The program also includes an interagency task force to coordinate efforts across government departments, involving the Secretaries of Veterans Affairs, Health and Human Services, Defense, and the Attorney General.

The bill was introduced in the House of Representatives on August 3, 2026, and referred to the Committee on Veterans' Affairs. It has not advanced beyond this stage. If enacted, the pilot program would run for two years, with the possibility of extension if the Secretary deems it effective in improving health outcomes for participating veterans. The program would also involve a study on treatment barriers and a report to Congress.

Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.

Timeline

  1. 10 Aug 2026

    Referred to the Subcommittee on Health.

Common questions

What does H.R. 10037 do?
H.R. 10037, the Virtual-Based Opioid Treatment for Veterans Act, proposes a pilot program to expand access to virtual opioid treatment for veterans. The Secretary of Veterans Affairs would be directed to establish this program within 180 days of enactment. The program would involve outreach to veterans and their families about virtual treatment options, developing referral networks designed to overcome treatment barriers, and creating a referral pipeline to these programs. It would also ensure healthcare providers and peer support specialists are informed about these virtual options. This bill primarily affects veterans enrolled in the Department of Veterans Affairs' patient enrollment system. It aims to provide them with alternative treatment methods for opioid use disorder, particularly those facing difficulties accessing traditional in-person care. The program also includes an interagency task force to coordinate efforts across government departments, involving the Secretaries of Veterans Affairs, Health and Human Services, Defense, and the Attorney General. The bill was introduced in the House of Representatives on August 3, 2026, and referred to the Committee on Veterans' Affairs. It has not advanced beyond this stage. If enacted, the pilot program would run for two years, with the possibility of extension if the Secretary deems it effective in improving health outcomes for participating veterans. The program would also involve a study on treatment barriers and a report to Congress.
Has H.R. 10037 become law?
The source does not supply a confirmed lifecycle stage for H.R. 10037. Check the latest action and official source below.
Who sponsored H.R. 10037?
H.R. 10037 was sponsored by Rep. Ross, Deborah K. [D-NC-2] (D-NC), with 2 cosponsors.
What's the latest action on H.R. 10037?
Referred to the Subcommittee on Health. (10 Aug 2026).

Related bills in Armed Forces and National Security

More bills from Rep. Ross, Deborah K. [D-NC-2]

Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.